10P Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer: Is it time to rethink standard of care?
F.M. Djuraev1Oncology Branch, Urologic Complex Clinic, Tashkent, UzbekistanA.S. Abdujapparov2Radiation Oncology, Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan
Ochiq kirishOltin
Litsenziya: cc-by-nc-nd
ABI
Annotatsiya
Background: Detection of residual tumor after radio-chemotherapy (RCX) in patients with locally advanced cervical cancer creates problems in clinical management.The aim of study is to evaluate the survival effect and prognostic importance of the residual tumor limited to the uterus in patients with advanced cervical cancer who received primary RCX.
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba